Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Inhaled steroids with and without regular salmeterol for asthma: serious adverse events.

Cates CJ, Schmidt S, Ferrer M, Sayer B, Waterson S.

Cochrane Database Syst Rev. 2018 Dec 3;12:CD006922. doi: 10.1002/14651858.CD006922.pub4.

PMID:
30521673
2.

Tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils): a systematic review and meta-analysis.

Petsky HL, Cates CJ, Kew KM, Chang AB.

Thorax. 2018 Dec;73(12):1110-1119. doi: 10.1136/thoraxjnl-2018-211540. Epub 2018 Jun 1.

PMID:
29858277
3.

Methods for including information from multi-arm trials in pairwise meta-analysis.

Rücker G, Cates CJ, Schwarzer G.

Res Synth Methods. 2017 Dec;8(4):392-403. doi: 10.1002/jrsm.1259. Epub 2017 Aug 25.

PMID:
28759708
4.

Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease.

Puhan MA, Gimeno-Santos E, Cates CJ, Troosters T.

Cochrane Database Syst Rev. 2016 Dec 8;12:CD005305. doi: 10.1002/14651858.CD005305.pub4. Review.

5.

Vitamin D for the management of asthma.

Martineau AR, Cates CJ, Urashima M, Jensen M, Griffiths AP, Nurmatov U, Sheikh A, Griffiths CJ.

Cochrane Database Syst Rev. 2016 Sep 5;9:CD011511. doi: 10.1002/14651858.CD011511.pub2. Review.

6.

Home telemonitoring and remote feedback between clinic visits for asthma.

Kew KM, Cates CJ.

Cochrane Database Syst Rev. 2016 Aug 3;(8):CD011714. doi: 10.1002/14651858.CD011714.pub2. Review.

PMID:
27486836
7.

Remote versus face-to-face check-ups for asthma.

Kew KM, Cates CJ.

Cochrane Database Syst Rev. 2016 Apr 18;4:CD011715. doi: 10.1002/14651858.CD011715.pub2. Review.

PMID:
27087257
8.

This Cochrane Review is closed: deciding what constitutes enough research and where next for pulmonary rehabilitation in COPD.

Lacasse Y, Cates CJ, McCarthy B, Welsh EJ.

Cochrane Database Syst Rev. 2015 Nov 18;(11):ED000107. doi: 10.1002/14651858.ED000107. No abstract available.

PMID:
26593129
9.

Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease.

Farne HA, Cates CJ.

Cochrane Database Syst Rev. 2015 Oct 22;(10):CD008989. doi: 10.1002/14651858.CD008989.pub3. Review.

PMID:
26490945
10.

Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease.

Poole P, Chong J, Cates CJ.

Cochrane Database Syst Rev. 2015 Jul 29;(7):CD001287. doi: 10.1002/14651858.CD001287.pub5. Review. Update in: Cochrane Database Syst Rev. 2019 May 20;5:CD001287.

PMID:
26222376
11.

Effects of opioid, hypnotic and sedating medications on sleep-disordered breathing in adults with obstructive sleep apnoea.

Mason M, Cates CJ, Smith I.

Cochrane Database Syst Rev. 2015 Jul 14;(7):CD011090. doi: 10.1002/14651858.CD011090.pub2. Review.

PMID:
26171909
12.

Assessing the methodological quality of systematic reviews.

Welsh EJ, Normansell RA, Cates CJ.

NPJ Prim Care Respir Med. 2015 Mar 19;25:15019. doi: 10.1038/npjpcrm.2015.19. No abstract available.

13.

Indacaterol, a once-daily beta2-agonist, versus twice-daily beta₂-agonists or placebo for chronic obstructive pulmonary disease.

Geake JB, Dabscheck EJ, Wood-Baker R, Cates CJ.

Cochrane Database Syst Rev. 2015 Jan 10;1:CD010139. doi: 10.1002/14651858.CD010139.pub2. Review.

14.

The Cochrane Library and safety of systemic corticosteroids for acute respiratory conditions in children: an overview of reviews.

Fernandes RM, Oleszczuk M, Woods CR, Rowe BH, Cates CJ, Hartling L.

Evid Based Child Health. 2014 Sep;9(3):733-47. doi: 10.1002/ebch.1980. Review.

PMID:
25236311
15.

Long-acting beta-agonists plus inhaled corticosteroids safety: a systematic review and meta-analysis of non-randomized studies.

Hernández G, Avila M, Pont A, Garin O, Alonso J, Laforest L, Cates CJ, Ferrer M; ASTRO-LAB group.

Respir Res. 2014 Jul 19;15:83. doi: 10.1186/1465-9921-15-83. Review.

16.

Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis.

Kew KM, Dias S, Cates CJ.

Cochrane Database Syst Rev. 2014 Mar 26;(3):CD010844. doi: 10.1002/14651858.CD010844.pub2. Review.

PMID:
24671923
17.

Safety of regular formoterol or salmeterol in adults with asthma: an overview of Cochrane reviews.

Cates CJ, Wieland LS, Oleszczuk M, Kew KM.

Cochrane Database Syst Rev. 2014 Feb 6;(2):CD010314. doi: 10.1002/14651858.CD010314.pub2. Review.

PMID:
24504983
18.

Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma.

Cates CJ, Welsh EJ, Rowe BH.

Cochrane Database Syst Rev. 2013 Sep 13;(9):CD000052. doi: 10.1002/14651858.CD000052.pub3. Review.

PMID:
24037768
19.

Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events.

Cates CJ, Jaeschke R, Schmidt S, Ferrer M.

Cochrane Database Syst Rev. 2013 Jun 7;(6):CD006924. doi: 10.1002/14651858.CD006924.pub3. Review.

PMID:
23744625
20.

Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease.

Welsh EJ, Cates CJ, Poole P.

Cochrane Database Syst Rev. 2013 May 31;(5):CD007891. doi: 10.1002/14651858.CD007891.pub3. Review.

PMID:
23728670
21.
22.

Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events.

Cates CJ, Jaeschke R, Schmidt S, Ferrer M.

Cochrane Database Syst Rev. 2013 Mar 28;(3):CD006922. doi: 10.1002/14651858.CD006922.pub3. Review. Update in: Cochrane Database Syst Rev. 2018 Dec 03;12:CD006922.

PMID:
23543548
23.

Vaccines for preventing influenza in people with asthma.

Cates CJ, Rowe BH.

Cochrane Database Syst Rev. 2013 Feb 28;(2):CD000364. doi: 10.1002/14651858.CD000364.pub4. Review.

PMID:
23450529
24.

Safety of regular formoterol or salmeterol in children with asthma: an overview of Cochrane reviews.

Cates CJ, Oleszczuk M, Stovold E, Wieland LS.

Cochrane Database Syst Rev. 2012 Oct 17;10:CD010005. doi: 10.1002/14651858.CD010005.pub2. Review.

25.

Ionisers for chronic asthma.

Blackhall K, Appleton S, Cates CJ.

Cochrane Database Syst Rev. 2012 Sep 12;(9):CD002986. doi: 10.1002/14651858.CD002986.pub2. Review.

26.

Alexander technique for chronic asthma.

Dennis JA, Cates CJ.

Cochrane Database Syst Rev. 2012 Sep 12;(9):CD000995. doi: 10.1002/14651858.CD000995.pub2. Review.

27.

Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.

Poole P, Black PN, Cates CJ.

Cochrane Database Syst Rev. 2012 Aug 15;(8):CD001287. doi: 10.1002/14651858.CD001287.pub4. Review. Update in: Cochrane Database Syst Rev. 2015;(7):CD001287.

PMID:
22895919
28.
29.

Regular treatment with formoterol for chronic asthma: serious adverse events.

Cates CJ, Cates MJ.

Cochrane Database Syst Rev. 2012 Apr 18;(4):CD006923. doi: 10.1002/14651858.CD006923.pub3. Review.

30.

Anticholinergic therapy for acute asthma in children.

Teoh L, Cates CJ, Hurwitz M, Acworth JP, van Asperen P, Chang AB.

Cochrane Database Syst Rev. 2012 Apr 18;(4):CD003797. doi: 10.1002/14651858.CD003797.pub2. Review.

PMID:
22513916
31.

Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events.

Cates CJ, Lasserson TJ.

Cochrane Database Syst Rev. 2012 Mar 14;(3):CD007695. doi: 10.1002/14651858.CD007695.pub3. Review.

32.

Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.

Spencer S, Karner C, Cates CJ, Evans DJ.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD007033. doi: 10.1002/14651858.CD007033.pub3. Review.

33.

Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.

Spencer S, Evans DJ, Karner C, Cates CJ.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD007033. doi: 10.1002/14651858.CD007033.pub2. Review. Update in: Cochrane Database Syst Rev. 2011;(12):CD007033.

PMID:
21975759
34.

The effect of adding inhaled corticosteroids to tiotropium and long-acting beta(2)-agonists for chronic obstructive pulmonary disease.

Karner C, Cates CJ.

Cochrane Database Syst Rev. 2011 Sep 7;(9):CD009039. doi: 10.1002/14651858.CD009039.pub2. Review.

35.

Safety of tiotropium.

Cates CJ.

BMJ. 2011 Jun 14;342:d2970. doi: 10.1136/bmj.d2970. No abstract available.

PMID:
21672998
36.

Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.

Ducharme FM, Lasserson TJ, Cates CJ.

Cochrane Database Syst Rev. 2011 May 11;(5):CD003137. doi: 10.1002/14651858.CD003137.pub4. Review. Update in: Cochrane Database Syst Rev. 2014;1:CD003137.

PMID:
21563136
37.
39.

Bronchodilator treatment and asthma death: a new analysis of a British case-control study.

Butland BK, Anderson HR, Cates CJ.

Respir Med. 2011 Apr;105(4):549-57. doi: 10.1016/j.rmed.2010.10.008. Epub 2010 Oct 29.

40.

A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils).

Petsky HL, Cates CJ, Lasserson TJ, Li AM, Turner C, Kynaston JA, Chang AB.

Thorax. 2012 Mar;67(3):199-208. doi: 10.1136/thx.2010.135574. Epub 2010 Oct 11. Review.

PMID:
20937641
41.

Formoterol versus short-acting beta-agonists as relief medication for adults and children with asthma.

Welsh EJ, Cates CJ.

Cochrane Database Syst Rev. 2010 Sep 8;(9):CD008418. doi: 10.1002/14651858.CD008418.pub2. Review.

42.

Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease.

Welsh EJ, Cates CJ, Poole P.

Cochrane Database Syst Rev. 2010 May 12;(5):CD007891. doi: 10.1002/14651858.CD007891.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;5:CD007891.

PMID:
20464758
43.
44.

Caffeine for asthma.

Welsh EJ, Bara A, Barley E, Cates CJ.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD001112. doi: 10.1002/14651858.CD001112.pub2. Review.

PMID:
20091514
45.

Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events.

Cates CJ, Lasserson TJ.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD007695. doi: 10.1002/14651858.CD007695.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;3:CD007695.

PMID:
19821436
46.

Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults.

Petsky HL, Cates CJ, Li A, Kynaston JA, Turner C, Chang AB.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD006340. doi: 10.1002/14651858.CD006340.pub3. Review.

PMID:
19821360
47.

Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events.

Cates CJ, Lasserson TJ, Jaeschke R.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD006922. doi: 10.1002/14651858.CD006922.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;3:CD006922.

PMID:
19588410
48.

Combination formoterol and budesonide as maintenance and reliever therapy versus inhaled steroid maintenance for chronic asthma in adults and children.

Cates CJ, Lasserson TJ.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD007313. doi: 10.1002/14651858.CD007313.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;4:CD007313.

49.

Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events.

Cates CJ, Lasserson TJ, Jaeschke R.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD006924. doi: 10.1002/14651858.CD006924.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;6:CD006924.

PMID:
19370661
50.

Culture-specific programs for children and adults from minority groups who have asthma.

Bailey EJ, Cates CJ, Kruske SG, Morris PS, Brown N, Chang AB.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD006580. doi: 10.1002/14651858.CD006580.pub4. Review. Update in: Cochrane Database Syst Rev. 2017 Aug 22;8:CD006580.

PMID:
19370643

Supplemental Content

Loading ...
Support Center